Skip to main content

Mike Emanuele Receives V Foundation for Cancer Research Award

October 2, 2013

Dr. Mike Emanuele, recipient of V Foundation for Cancer Research Award Dr. Mike Emanuele has received a V Scholar Award from the V Foundation for Cancer Research. The title of Mike’s research proposal is “Identification of ubiquitin signaling networks as novel avenues for therapeutic intervention.” Mike’s award is for $200,000 over 2 years. Our congratulations … Read more

Two New Faculty Join the Pharmacology Department

August 15, 2013

Dr. Juan Song, Ph.D. and Dr. Mauro Calabrese, Ph.D. have joined the Pharmacology Department as Assistant Professors. Dr. Song will begin in September, 2013 and Dr. Calabrese will join us starting in March, 2014. Meet Dr. Song and Dr. Calabrese A few words from Dr.Juan Song to introduce herself: I’ll be starting as an Assistant … Read more

Henrik Dohlman Elected Associate Editor of JBC

May 22, 2013

Dr Henrik Dohlman, newly elected Associate Editor for JBC Henrik Dohlman, Ph.D., a joint faculty member of the Department of Pharmacology has been elected as an Associate Editor for the Journal of Biological Chemistry (JBC). Dr. Dohlman is currently an editorial board member of JBC with https://www.med.unc.edu/pharm/directory/henrik-dohlman-phd/an area of expertise in signal transduction. He will … Read more

Samulski Lab clinical trials results for Canavan Disease treatment published in Science Translational Medicine

January 24, 2013

Canavan disease is an autosomal recessive degenerative neurological disorder caused by defective ASPA gene. ASPA is responsible for the production of the enzyme aspartoacylase, an enzyme essential for breaking down concentrated brain molecule N-acetyl aspartate. The lack of this breakdown interferes with growth of myelin sheath of the nerve fiber, and as a result, symptoms … Read more